Everything tagged "growth" across research, earnings, and macro.
192 articles
BridgeBio has evolved from a pipeline biotech into a commercial-stage rare-disease story, led by explosive Attruby sales and a late-stage pipeline. The stock still carries meaningful balance-sheet risk, but the launch momentum is real.
Alnylam has evolved into a commercial RNAi leader, with AMVUTTRA powering rapid revenue growth and a strong balance sheet supporting the next leg. The stock earns a Buy as the TTR franchise scales and profitability improves.
Oracle is transforming from a legacy software giant into an AI infrastructure and cloud growth story. The upside is massive backlog and accelerating cloud revenue, but the buildout is pressuring free cash flow and leverage.
Rocket Lab is scaling fast across launch and spacecraft systems, with Q1 2026 revenue up 63.5% and backlog at $2.2B. The stock looks attractive for investors willing to underwrite Neutron execution and margin conversion.
Vicor is gaining traction in AI infrastructure and power-density applications, with revenue, backlog, and Advanced Products all accelerating. The stock looks strong operationally but expensive, so the report lands on Hold.
AMD is evolving into a data center and AI infrastructure story, with Q1 2026 revenue up 38% and Data Center sales up 57%. The business is strengthening, but the stock already discounts much of the AI upside.
Alibaba is a Buy as cloud and AI monetization accelerate, even as heavy investment pressures near-term margins and cash flow. The stock looks restrained relative to its growth pockets and balance sheet strength.
ON Semiconductor is emerging from a cyclical reset with improving demand, accelerating AI data center exposure, and early traction in Treo. The stock looks constructive for investors willing to underwrite execution risk and valuation.
FormFactor is benefiting from record revenue, stronger HBM demand, and rising exposure to AI infrastructure test complexity. The stock looks attractive on execution, but valuation already reflects much of the progress.
Santander is delivering record profits, improving efficiency, and using Openbank to lower funding costs and expand returns. The stock looks like a Buy for investors who want a diversified global bank with solid capital and visible earnings momentum.
Shopify is still growing fast, with Q1 2026 revenue up 34% and GMV up 35%, but the stock already reflects a lot of that strength. The report is constructive on the business and cautious on valuation, leading to a Hold view.
Synchrony Financial is posting strong profitability, improving credit trends, and aggressive capital returns while trading at a depressed earnings multiple. The report argues the stock still has room to rerate if execution remains steady.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator